#USA #New York #Class Action #Levi Korsinsky #Skye Bioscience

Skye Bioscience, Inc. Class Action Lawsuit Deadline for Lead Plaintiff Approaches

Important Announcement for Skye Bioscience Investors

Levi & Korsinsky, LLP has issued a critical notification for investors linked to Skye Bioscience, Inc. regarding a pending class action lawsuit. If you have invested in Skye Bioscience (NASDAQ: SKYE), it's essential to be aware of the circumstances surrounding the case and your potential legal options.

Class Action Overview

The lawsuit seeks to represent investors who experienced financial losses due to alleged securities fraud that occurred between November 4, 2024, and October 3, 2025. The main claim is that Skye Bioscience misrepresented the effectiveness of its product candidate, nimacimab, leading investors to have inflated expectations regarding its prospects.

Key Allegations

The filed complaint asserts that:
1. Misleading Information: The claims made by the defendants falsely suggested that nimacimab was more effective than it actually is.
2. Inflated Market Expectations: Due to these misstatements, the clinical and commercial potential of nimacimab was exaggerated.
3. Material Misleading Statements: The public communications made by the defendants did not reflect the reality of the product's effectiveness and prospects.

What Investors Should Do

If you are a Skye Bioscience investor and incurred a loss during the specified period, it is crucial to act promptly. You have until January 16, 2026, to request the Court to appoint you as a lead plaintiff in this case. However, wanting to serve in this capacity is not a requirement to engage in any recovery process—any class member may still benefit regardless of their lead status.

No Financial Risks Involved

Encouragingly, there is no financial obligation for class members willing to join the lawsuit. Participants may receive compensation without incurring any fees or out-of-pocket costs, making this an accessible path for affected investors to seek redress for their losses.

Why Choose Levi & Korsinsky?

Levi & Korsinsky possesses extensive experience in securities litigation, having recovered hundreds of millions of dollars for shareholders throughout their 20-year history. Their team specializes in complex cases involving investor rights, boasting a roster of over 70 dedicated professionals ready to assist clients. The firm has consistently ranked among the top securities litigation firms based on their track record.

Contact Information

Interested investors can reach out to Joseph E. Levi, Esq. for further details and assistance:

It’s vital for affected investors to make an informed decision swiftly, as the deadline approaches. Acting promptly can significantly impact one's ability to participate in the lawsuit and pursue rightful compensation. Be sure to secure your voice in this class action for potential recovery of your losses within the given timeframe.